First, we examined whether a single administration of the TrkB antagonist ANA-12 and the TrkB agonist 7,8-DHF could affect behavioral abnormalities (depression and behavioral sensitization) in mice after repeated METH administration. This evidence concerns the gene NTRK2 and depressive symptom measurement.